You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable Melanoma

Showing 1 - 25 of 3,771
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Tampa, Florida
  • +1 more
Jan 30, 2023

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Pathologic Stage III Cutaneous Melanoma AJCC v8 Trial in United States (Imprime PGG, Pembrolizumab)

Withdrawn
  • Pathologic Stage III Cutaneous Melanoma AJCC v8
  • Imprime PGG
  • Pembrolizumab
  • La Jolla, California
  • +3 more
Oct 29, 2021

Melanoma Trial in Italy (Cobimetinib 20 MG Oral Tablet, Vemurafenib 240 Mg Oral Capsule, Atezolizumab 1200 MG in 20 ML

Recruiting
  • Melanoma
  • Cobimetinib 20 MG Oral Tablet
  • +2 more
  • Bagno A Ripoli, Firenze, Italy
  • +5 more
Apr 12, 2022

Melanoma Trial in Salt Lake City (Nivolumab, HF10)

Terminated
Has Results
  • Melanoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 9, 2022

Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Sydney, New South Wales, Australia
  • +2 more
Apr 4, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Ipilimumab
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 11, 2022

Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of

Recruiting
  • Resectable Melanoma
  • +2 more
  • BCD-217
  • +3 more
  • Lesnoy, Belarus
  • +35 more
Feb 21, 2023

Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Amsterdam, NH, Netherlands
    Antoni van Leeuwenhoek ziekenhuis
Feb 11, 2022

Melanoma, Squamous Cell Carcinoma of Head and Neck Trial (IO102-IO103, Pembrolizumab)

Not yet recruiting
  • Melanoma
  • Squamous Cell Carcinoma of Head and Neck
  • (no location specified)
Nov 7, 2022

Cutaneous Melanoma Trial in Houston (Atezolizumab)

Recruiting
  • Cutaneous Melanoma
  • Houston, Texas
    Houston Methodist Hospital
Dec 28, 2021

Melanoma Trial in Norway (BGB324+pembrolizumab, BGB324+dabrafenib and trametinib, pembrolizumab)

Active, not recruiting
  • Melanoma
  • Bergen, Norway
  • +4 more
Aug 24, 2022

metAsTatI? melanOma Treated With dabrafeNib and trAmetinib in

Recruiting
  • Melanoma Stage III
  • +2 more
  • Barnaul, Alatai, Russian Federation
  • +14 more
May 29, 2022

Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Nov 21, 2023

Acral Melanoma Trial in Changchun (SHR-1210+Apatinib)

Recruiting
  • Acral Melanoma
  • Changchun, Jilin, China
    The first hospital of Jilin University
May 24, 2021

Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Dostarlimab (TSR-042) (singly)
  • Dostarlimab (TSR-042) and TSR-022 (combination)
  • Washington, District of Columbia
  • +2 more
Feb 22, 2022

Head and Neck Mucosal Melanomas Trial in Villejuif (drug, procedure, radiation)

Recruiting
  • Head and Neck Mucosal Melanomas
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)

Recruiting
  • Liver Metastases
  • +10 more
  • DNX-2440
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute, Inc.
Mar 28, 2022

Melanoma Trial in Germany (PTK787/ZK 222584, Dacarbazine)

Terminated
  • Melanoma
  • Essen, Germany
  • +3 more
Sep 28, 2021

Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma Trial in Philadelphia (FDG PET/CT imaging)

Terminated
  • Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma
  • FDG PET/CT imaging
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 19, 2021

Mucosal Melanoma, Neoadjuvant Treatment Trial in Beijing (Lenvatinib, Pembrolizumab)

Not yet recruiting
  • Mucosal Melanoma
  • Neoadjuvant Treatment
  • Lenvatinib, Pembrolizumab
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 10, 2020

Metastatic Melanoma Trial in Worldwide (Masitinib, Dacarbazine)

Terminated
  • Metastatic Melanoma
  • Charlotte, North Carolina
  • +8 more
Nov 3, 2020

Melanoma Trial in Houston (Temozolomide (TMZ), Pegylated Interferon Alpha-2b (PGI))

Completed
Has Results
  • Melanoma
  • Temozolomide (TMZ)
  • Pegylated Interferon Alpha-2b (PGI)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 1, 2020